ALHC: financial statements from SEC — TradeAlmanac

ALHC

Alignment Healthcare, Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	Dec 31, 2025	Dec 31, 2024
Revenue	—	2.70bn
Selling, general and administrative	—	371m
Operating expenses	—	2.81bn
Operating income	—	−102m
Pre-tax income	—	−128m
Income tax	—	21,000
Net income	−724,000	−128m
Earnings per share	—	−0.67
Earnings per share, diluted	—	−0.67
Weighted average shares	—	191m
Weighted average shares, diluted	—	191m

Balance sheet

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Cash and equivalents	706m	578m	618m	470m	446m	435m	340m	339m
Short-term investments	21m	28m

Cash flow

Metric	Dec 31, 2025	Dec 31, 2024
Operating cash flow	140m	35m
Depreciation and amortisation	—	27m
Share-based compensation	—	71m
Capital expenditure	—	41m
Investing cash flow	−15m	39m
Financing cash flow

Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)